Synthesis and antifungal activity of new 1-halogenobenzyl-3-imidazolylmethylindole derivatives
作者:Y Na
DOI:10.1016/s0223-5234(02)00005-3
日期:2003.1
A series of 1-benzyl-3-(imidazol-1-ylmethyl)indole derivatives 35-46 were prepared under mild reaction conditions and tested for their antifungal activity. Pharmacomodulation at N(1), C(2) and C(5) of the indole ring and at the level of the alkyl chain (R(1)) was carried out starting from the corresponding 3-acylindoles 6, 7 or 3-formylindoles 11-22. Target imidazolyl compounds 35-46 were obtained
在温和的反应条件下制备了一系列的1-苄基-3-(咪唑-1-基甲基)吲哚衍生物35-46,并测试了它们的抗真菌活性。从相应的3-acylindoles 6、7或3-开始在吲哚环的N(1),C(2)和C(5)以及烷基链(R(1))上进行药物调节。甲酰基吲哚11-22。通过从中间体氨基甲酸酯中消除CO(2),以令人满意的产率获得了目标咪唑基化合物35-46。所有化合物均在体外针对两种人类真菌病原体,白色念珠菌(CA980001)和烟曲霉(AF980003)进行了评估。两性霉素B,氟康唑和伊曲康唑用作参考。27种化合物中的7种(35b,35e,35g,35h,36a,38a,尤其是40a)对白色念珠菌具有显着的抗真菌活性,MIC范围为1-6微克mL(-1)。关于对烟曲霉的抑制活性,与参考药物两性霉素B和伊曲康唑的MIC(90)和MIC(80)相比,我们大多数化合物的MIC值均超过20微克mL(-1)。值分别为0